Concentra Group Holdings Parent, Inc. (CON)

Concentra Group Holdings Parent, Inc. had its IPO on July 24, 2024, at $23.50 per share, offering 22.5 million shares to raise $529 million. The stock trades on the NYSE under the symbol CON. The lock-up period expires on January 21, 2025, and the quiet period expired on September 3, 2024. As of February 4, 2026, the stock's 52-week range was $18.55 - $23.99. Analysts currently have a "Buy" rating for CON with a price target of $30.67.

Information regarding demand seasonality for Concentra Group Holdings Parent, Inc.'s products and services was not found in the provided search results.

Concentra Group Holdings Parent, Inc. operates in the healthcare and medical services sector, providing medical care facilities and specialty outpatient facilities. Founded in 1979, it is a leading provider of occupational health services in the United States. Concentra offers occupational health services, urgent care, physical therapy, employer-sponsored primary care, wellness programs, telemedicine, pharmacy services, and medical compliance administration. In 2024, Concentra reported revenues of $1.90 billion, a 3.38% increase from the previous year.

Concentra Group Holdings Parent, Inc. has a significant national presence across the United States. As of March 31, 2024, the company operated 547 stand-alone occupational health centers in 41 states and 151 onsite health clinics at employer worksites in 37 states. Its telemedicine program serves 43 states and the District of Columbia. In total, Concentra delivers services across 45 states and the District of Columbia, treating more than 50,000 patients each business day.

Information regarding Concentra Group Holdings Parent, Inc.'s brand reputation in the past year and any specific events affecting it was not found in the provided search results.

In connection with its IPO, Concentra Group Holdings Parent, Inc. issued common stock representing not more than 19.9% of its outstanding common stock, with Select Medical Corporation maintaining ownership of at least 80.1% of Concentra's common stock, indicating that Select Medical Corporation is a major institutional owner.